VEEV:NYE-Veeva Systems Inc. Class A (USD)

EQUITY | Health Information Services | New York Stock Exchange

Last Closing

USD 234.49

Change

-3.57 (-1.50)%

Market Cap

USD 6.08B

Volume

2.20M
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Veeva Systems Inc is a provider of industry-specific, cloud-based software solutions for the life sciences industry.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-28 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
DOCS Doximity Inc

N/A

USD 11.11B
WEAV Weave Communications Inc

N/A

USD 0.72B
AMWL American Well Corp

N/A

USD 0.11B
CTEV Claritev Corporation

N/A

N/A
HNGE Hinge Health, Inc.

N/A

N/A
EVH Evolent Health Inc

N/A

N/A
PHR Phreesia Inc

N/A

N/A
TDOC Teladoc Inc

N/A

N/A
FOXO FOXO Technologies Inc.

N/A

N/A

ETFs Containing VEEV

EKG First Trust Nasdaq Lux Di.. 8.89 % 0.00 %

N/A

USD 3.28M
CURG:LSE VanEck Genomics and Healt.. 7.17 % 0.00 %

N/A

USD 4.76M
HHIF:AU HEJAZ High Innovation Act.. 6.74 % 0.00 %

N/A

N/A
CURE:XETRA VanEck Genomics and Healt.. 5.89 % 0.00 %

N/A

N/A
FDHT:XETRA 4.82 % 0.00 %

N/A

N/A
FDHT Fidelity Covington Trust .. 4.61 % 0.00 %

N/A

USD 8.09M
FDOC:LSE 4.11 % 0.00 %

N/A

N/A
MOGB:LSE VanEck Morningstar US Sus.. 3.64 % 0.00 %

N/A

USD 0.41B
MOAT:SW VanEck Morningstar US Sus.. 3.18 % 0.00 %

N/A

N/A
MOTV:LSE VanEck Morningstar US Wid.. 2.62 % 0.00 %

N/A

USD 0.06B
MOTU:LSE VanEck Morningstar US Wid.. 2.62 % 0.00 %

N/A

USD 0.06B
MOAT:AU VanEck Morningstar Wide M.. 2.59 % 0.00 %

N/A

USD 1.04B
MHOT:AU VanEck Morningstar Wide M.. 2.57 % 0.00 %

N/A

N/A
KLWD:LSE WisdomTree Cloud Computin.. 1.93 % 0.00 %

N/A

USD 0.30B
WCLD:LSE WisdomTree Cloud Computin.. 1.93 % 0.00 %

N/A

USD 0.30B
WCLD:SW 1.76 % 0.00 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

N/A

N/A
QRH:CA 0.00 % 1.20 %

N/A

N/A
EASI 0.00 % 0.75 %

N/A

N/A
WELL:LSE Hanetf Icav - Han-Gins He.. 0.00 % 0.00 %

N/A

N/A
GMVM:XETRA VanEck Morningstar US Sus.. 0.00 % 0.00 %

N/A

N/A
VMOM:XETRA 0.00 % 0.00 %

N/A

N/A
LCG Sterling Capital Focus Eq.. 0.00 % 0.00 %

N/A

USD 0.03B
EDOC Global X Telemedicine & D.. 0.00 % 0.00 %

N/A

USD 0.04B

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.53% 88% B+ 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.53% 88% B+ 86% B+
Trailing 12 Months  
Capital Gain 16.95% 75% C 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.95% 75% C 79% B-
Trailing 5 Years  
Capital Gain 7.14% 100% F 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.14% 100% F 25% F
Average Annual (5 Year Horizon)  
Capital Gain -2.41% 40% F 25% F
Dividend Return -2.41% 40% F 15% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 23.22% 90% A- 42% F
Risk Adjusted Return -10.39% 20% F 18% F
Market Capitalization 6.08B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Health Information Services) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 109.90 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector